Leveraging the potential of genomic sequencingFriday 11 november 2022 16:15 - 17:15
Genomic sequencing is a ground-breaking technology that can bring countless benefits to public health, agriculture, the environment, and more. The use of pathogen genomics proved decisive during the Covid pandemic, enabling early viral identification, design of diagnostics, vaccines, and therapeutics, and tracking of variants of concern. Efforts to make this versatile technology accessible globally must be sustained to prepare for future threats. Existing scientific centers of excellence in both Global South and Global North are paving the way to using this technology for specific needs such as disease surveillance. However, international cooperation to enable a wide, sustainable distribution and broader implementation of this technology has yet to emerge. Governance questions related to strengthening genomic capacity and implementation are just beginning to be considered by states, regional & global institutions, including on data sharing, economic opportunities, and bioethics. Building on successful examples, this session will bring together scientists, private sector, government, and multilateral actors to explore conditions for the responsible development and sustainability of genomics.
Including the participation of (5)
Chief Public Affairs Officer, Illumina
Assistant Director-General for Health Emergency Intelligence, World Health Organization
Senior Advisor, Africa Pathogen Genomics Initiative, Africa CDC
President, Foundation for Influenza Epidemiolgy, Global Influenza Hospital Surveillance Network
Former Minister of Health, Republic of Guinea-Bissau